BSE filing, NSE: SUNPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Sun Pharmaceutical Industries Ltd: key numbers
- Share price
- ₹1,805.30
- Market cap
- ₹4,33,152 Cr
- Revenue (annual)
- ₹58,462 Cr
- Net profit (annual)
- ₹11,479 Cr
- P/E (TTM)
- 35.8×Sector 48.7×
- Promoter holding
- 52.68%-1.80% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sun Pharmaceutical Industries Ltd
All →Sun Pharmaceutical Industries Q2 FY27 Results: Net Profit ₹1,995 Cr, Down 36.2% YoY
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹16,199 Cr (+11.9% YoY) and net profit of ₹1,995 Cr (-36.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,995 Cr · -36.2% YoY
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
Sun Pharmaceutical Industries Debt & Borrowing: ₹7,816 Cr
Sun Pharma completed allotment of ₹7,816 crore NCDs via private placement, exercising its greenshoe option of ₹816 crore. The unsecured debentures carry 8.05–8.20% coupons maturing October 2031.
- Value
- ₹7,816 Cr
- Execution
- 5 years and 1 day (26 Oct 2026 to 27 Oct 2031)
Sun Pharmaceutical Industries Business Update
Sun Pharma's drug UNLOXCYT received Category 2A preferred designation in updated NCCN guidelines for treating locally advanced cutaneous squamous cell carcinoma.
Sun Pharmaceutical Industries Other Announcement
Sun Pharmaceutical Industries submitted the quarterly confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, as received from their RTA.
Sun Pharmaceutical Industries Credit Rating
Sun Pharma received credit ratings from CRISIL and ICRA for its proposed NCD programme and reaffirmed existing facility ratings.
Other other announcement announcements
All →Vipul Other Announcement
Vipul Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing reports promoter and public holdings without any transaction or corporate event.
Loyal Textiles Mills Other Announcement
Loyal Textile Mills filed its quarterly shareholding pattern for the period ended 30 September 2026 under Regulation 31. It shows promoter holding of 1,274,603 shares (26.46%) plus promoter group, with one promoter's holding reduced to nil.
Kkalpana lndustries (India) Other Announcement
Kkalpana Industries filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 75.0% of equity.
West Leisure Resorts Other Announcement
West Leisure Resorts says Regulation 23(9) related party disclosures do not apply for the half year ended September 30, 2026. Capital and net worth fall below thresholds.
U H Zaveri Other Announcement
U. H. Zaveri Limited filed its quarterly shareholding pattern for the quarter ended September 30, 2026. The promoter and promoter group holds 39.27 percent, and public shareholding is 60.73 percent.
Shree Vasu Logistics Other Announcement
Shree Vasu Logistics filed its quarterly shareholding pattern as of October 23, 2026. Promoter and promoter group hold about 68.4% of the company's shares.